Avadel Tells Fed. Circ. It Should Be Free To Test Sleep Drug

By Andrew Karpan · October 2, 2024, 8:46 PM EDT

Specialty-drug maker Avadel Pharmaceuticals says a Delaware federal court went too far in blocking it from testing a narcolepsy drug to treat an uncommon sleep disorder after finding that it infringed...

To view the full article, register now.

Documents

Case Information

Case Title

Jazz Pharmaceuticals, Inc. v. Avadel CNS Pharmaceuticals, LLC

Case Number

24-2274

Court

Appellate - Federal Circuit

Nature of Suit

830 Patent Infringement (Fed. Qst.)

Date Filed

August 29, 2024